® ® 2 | --- | --- | |-------|------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | David Meeker, MD | | | | | | | | | | | | | | | | | 4 | Rhythm® | • More than 100 international patients on reimbursed IMCIVREE therapy • 25.5% mean BMI reduction achieved at one-year setmelanotide therapy (n=12) in LTE trial, as presented at ObesityWeek® • RM-718: IND on track for submission by year-end 2023 Weight Reduction in Patients with Hypothalamic Obesity Treated With Setmelanotide for 12 Months 4-Yea ...